Skip to Content

FRIDAY, 07 NOVEMBER 2025, 01:48

Education

Her Research Could Improve Training For Service Dogs

Yesterday at 16:30 PM, via New York Times

“This is a type of science that has an impact that most people could see in their homes,” said Erin Hecht, a canine researcher at Harvard. “Now there’s just no money.”

Science/Tech

iOS 26.2 to Allow Third-Party App Stores in Japan Ahead of Regulatory Deadline

Today at 01:25 AM, via Slashdot

Japan’s new competition rules are forcing Apple to open the iPhone to third-party app stores, and iOS 26.2 will quietly flip that switch ahead of the December deadline. MacRumors reports: According to a post shared on X by @Tzzlala, iPhones running the beta in Japan are able to install alternative app stores like AltStore PAL and Epic Games, and download apps from them, though Fortnite in-app...

Science/Tech

Cloudflare Tells US Govt That Foreign Site Blocking Efforts Are Digital Trade Barriers

Today at 00:45 AM, via Slashdot

An anonymous reader quotes a report from TorrentFreak: In a submission for the 2026 National Trade Estimate Report (PDF), Cloudflare warns the U.S. government that site blocking efforts cause widespread disruption to legitimate services. The complaint points to Italy’s automated Piracy Shield system, which reportedly blocked “tens of thousands” of legitimate sites. Meanwhile, overbroad IP...

Science/Tech

Tesla Investors Back Musk’s Trillion Dollar Payday

Yesterday at 23:56 PM, via New York Times

Shareholders approved a plan to grant Mr. Musk shares worth nearly $1 trillion if he meets ambitious goals, including vastly expanding the company’s stock market valuation.

Health

What Scientists Are Learning From Brain Organoids

Yesterday at 21:00 PM, via New York Times

Lab-grown “reductionist replicas” of the human brain are helping scientists understand fetal development and cognitive disorders, including autism. But ethical questions loom.

Health

Obesity Drugs May Drop to as Little as $150 a Month

Yesterday at 19:06 PM, via New York Times

President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money.